Migraine, Epilepsy Drug Topamax Linked To Birth Defects

Posted on Mar 12, 2011 in Uncategorized

Posted on 06 March 2011 by admin

Washington (SmartAboutHealth) – The migraine medication Topamax has been linked to an increased risk of birth defects by the U.S. Food and Drug Administration (FDA).

The FDA has come out and stated that Topamax, as well as the drug in its generic form, Topiramate, may greatly increase the risk of birth defects for babies who are born to mothers who use the drug.

The drug is commonly used to treat migraine headaches as wella s seizures in people.

What research has found though is that the drug can also lead to birth defects such as cleft lip, as well as cleft palate deformities.

These are known as oral birth defects, and the risk of developing them increases greatly due to the use of the drug.

Health officials are urging doctors to warn their female patients who may be ready to become pregnant about taking the medicine.

Women who take the medicine are 20 times more likely to give birth to a baby who has these birth defects.

These oral birth defects are very rare in this country, but do occur nonetheless.

Developmental issues later in life can result from the development of the birth defects.

Topamax is made by Teva Pharmaceutical Industries Ltd., as well as other generic drug makers.